RhumbLine Advisers’s Icosavax, Inc. Common Stock ICVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-42,538
| Closed | -$670K | – | 4292 |
|
|
2023
Q4 | $670K | Buy |
42,538
+1,767
| +4% | +$27.8K | ﹤0.01% | 2492 |
|
|
2023
Q3 | $316K | Buy |
40,771
+1,385
| +4% | +$10.7K | ﹤0.01% | 2905 |
|
|
2023
Q2 | $391K | Buy |
39,386
+4,746
| +14% | +$47.1K | ﹤0.01% | 2849 |
|
|
2023
Q1 | $201K | Buy |
34,640
+621
| +2% | +$3.6K | ﹤0.01% | 2739 |
|
|
2022
Q4 | $270K | Buy |
34,019
+1,414
| +4% | +$11.2K | ﹤0.01% | 2712 |
|
|
2022
Q3 | $103K | Buy |
32,605
+1,774
| +6% | +$5.6K | ﹤0.01% | 3000 |
|
|
2022
Q2 | $177K | Buy |
30,831
+10,469
| +51% | +$60.1K | ﹤0.01% | 2964 |
|
|
2022
Q1 | $143K | Buy |
20,362
+8,073
| +66% | +$56.7K | ﹤0.01% | 2830 |
|
|
2021
Q4 | $281K | Buy |
12,289
+264
| +2% | +$6.04K | ﹤0.01% | 2724 |
|
|
2021
Q3 | $356K | Buy |
+12,025
| New | +$356K | ﹤0.01% | 2695 |
|